Efficacy and tolerance of a 12-week treatment with inhaled formoterol in patients with reversible obstructive lung disease

Respiration

Volumn 61, Issue 6, 1994, Pages 305-309

  Stålenheim, Gunnemar ^a   Wegener, T ^a   Grettve, L ^b   Lundback B ^c   Melander, B ^d   Osterman, K ^e   Piitulainen, E ^f   Zetterstrom O ^e  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b Lung Clinic Norra Älvsborgs Länssjukhus ^*  (Sweden)

^c Lung Clinic Centrallasarettet ^*  (Sweden)

^d Ciba Geigy AB   (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adrenergic receptor agonists; Asthma; Bronchoconstriction; Bronchodilator agents

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; FORMOTEROL; SALBUTAMOL;

ADULT; AGED; APPETITE; ARTICLE; ASTHMA; BLOOD ANALYSIS; BRONCHOSPASM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSPNEA; DYSURIA; EDEMA; ELECTROCARDIOGRAM; EPISTAXIS; FATIGUE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCLE CRAMP; NAUSEA; NIGHT SLEEP; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SORE THROAT; SWEATING; TREMOR; URINALYSIS;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ADULT; AGED; ALBUTEROL; DOUBLE-BLIND METHOD; ETHANOLAMINES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE;

EID: 0028063491     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000196360     Document Type: Article

References (15)

1. Ida H: Cardiorespiratory activities of 3-for- mylamino-4-hydroxy-α-(N-1-methyl-2-p- methoxvphenethylaminomethyl) - benzylalco-holhemifumarate (BD 40 A) and some other β-adrenoceptor stimulants in conscious guinea pigs. Arzneimittel-Forschung 1976;26:1337-1340.
2. Ida H: Comparison of the action of BD 40 A and some other β-adrenoceptor stimulants on the isolated trachea and atria of the guinea pig. Arzneimittel-Forschung 1976;26:839-842.
3. Tasaka K: Formoterol (Atock(r)): A new orally active and selective β2-receptor stimulant. Drugs Today 1986;22:505-519.
4. Löfdahl CG, Svedmyr N: Effect and duration of inhaled formoterol, a new β2-adrenoceptor agonist, compared to salbutamol in asthmatic patients. Acta Pharmacol Toxicol 1986; suppl. 52:229.
5. von Berg A, Berdel A: Formoterol and salbutamol metered aerosols: Comparison of a new and an established beta-2-agonist for their bronchodilating efficacy in the treatment of childhood bronchial asthma. Pediatr Pulmonol 1989;7:89-93.
6. Becker AB, Simons FER, McMillan JL, Faridy T: Formoterol. a new long-acting selective β2-adrenergic receptor agonist: Double-blind comparison with salbutamol and placebo in children with asthma. J Allergy Clin Immunol 1989;84:891-895.
7. Graff-Lonnevig V, Browald L: Twelve hours’ bronchodilating effect of inhaled formoterol in children with asthma: A double-blind crossover study versus salbutamol. Clin Exp Allergy 1990;20:429-432.
8. Maesen FPV, Smeets JJ, Gubbelmans HLL, Zweers PGMA: Bronchodilator effect of inhaled formoterol vs. salbutamol over 12 hours. Chest 1990;97:590-594.
9. Hedenström H, Wegener T, Boman G, Wåhlander L, Melander B: Effect of inhaled formoterol versus tcrbutaline on respiratory function in moderate bronchial asthma. Allergy 1992;47:158-163.
10. Wegener T, Hedenström H, Melander B: Rapid onset of action of inhaled formoterol in asthmatic patients. Chest 1992;102:535-538.
11. Löfdahl C-G, Svedmyr N: Formoterol fuma-rate, a new βi-adrenoceptor agonist. Acute studies of selectivity and duration of effect after inhaled and oral administration. Allergy 1989;44:264-271.
12. Wallin A, Melander B, Rosenhall L, Sandström T, Wåhlander L: Formoterol, a new long acting betaj-agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma. Tnorax 1990;45:256-261.
13. Kesten S, Chapman KR, Broder I, Cartier A, Hyland RH, Knight A, Malo JL, Mazza JA, Moote DW, Small R, Tarlo S, Gontovnik L, Rebuck AS: A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma. Am Rev Respir Dis 1991;144:622-625.
14. Maesen FPV, Costongs R, Smeets JJ, Brombacher PJ, Zweers PGM: The effect of maximal doses of formoterol and salbutamol from metered dose inhaler on pulse rates, ECG, and scrum potassium concentrations. Chest 1991;99:1367-1373.
15. Arvidsson P, Larsson S, Löfdahl C-G, Melander B, Svedmyr N, Wåhlander L: Inhaled formoterol during one year in asthma: A comparison with salbutamol. Eur Respir J 1991;4:1168-1173.